Greece · Delayed Price · Currency is EUR Biokarpet Statistics
Total Valuation
Biokarpet has a market cap or net worth of EUR 35.36 million. The enterprise value is 141.28 million.
| Market Cap | 35.36M |
| Enterprise Value | 141.28M |
Important Dates
The last earnings date was Friday, September 25, 2026.
| Earnings Date | Sep 25, 2026 |
| Ex-Dividend Date | Aug 24, 2026 |
Share Statistics
Biokarpet has 23.99 million shares outstanding.
| Current Share Class | 23.99M |
| Shares Outstanding | 23.99M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.67% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 9.03.
| PE Ratio | 9.03 |
| Forward PE | n/a |
| PS Ratio | 0.16 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 14.58 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 36.09 |
| EV / Sales | 0.62 |
| EV / EBITDA | 8.78 |
| EV / EBIT | 15.36 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 2.28.
| Current Ratio | 1.76 |
| Quick Ratio | 1.19 |
| Debt / Equity | 2.28 |
| Debt / EBITDA | 7.49 |
| Debt / FCF | n/a |
| Interest Coverage | 1.81 |
Financial Efficiency
Return on equity (ROE) is 7.73% and return on invested capital (ROIC) is 4.88%.
| Return on Equity (ROE) | 7.73% |
| Return on Assets (ROA) | 2.55% |
| Return on Invested Capital (ROIC) | 4.88% |
| Return on Capital Employed (ROCE) | 5.70% |
| Weighted Average Cost of Capital (WACC) | 4.40% |
| Revenue Per Employee | 334,699 |
| Profits Per Employee | 5,756 |
| Employee Count | 680 |
| Asset Turnover | 1.01 |
| Inventory Turnover | 5.11 |
Taxes
In the past 12 months, Biokarpet has paid 771,244 in taxes.
| Income Tax | 771,244 |
| Effective Tax Rate | 16.28% |
Stock Price Statistics
The stock price has decreased by -22.01% in the last 52 weeks. The beta is 0.56, so Biokarpet's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | -22.01% |
| 50-Day Moving Average | 1.59 |
| 200-Day Moving Average | 1.66 |
| Relative Strength Index (RSI) | 40.14 |
| Average Volume (20 Days) | 15,630 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biokarpet had revenue of EUR 227.60 million and earned 3.91 million in profits. Earnings per share was 0.16.
| Revenue | 227.60M |
| Gross Profit | 35.96M |
| Operating Income | 9.20M |
| Pretax Income | 4.74M |
| Net Income | 3.91M |
| EBITDA | 14.45M |
| EBIT | 9.20M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
The company has 15.45 million in cash and 120.51 million in debt, with a net cash position of -105.06 million or -4.38 per share.
| Cash & Cash Equivalents | 15.45M |
| Total Debt | 120.51M |
| Net Cash | -105.06M |
| Net Cash Per Share | -4.38 |
| Equity (Book Value) | 52.81M |
| Book Value Per Share | 2.17 |
| Working Capital | 50.57M |
Cash Flow
In the last 12 months, operating cash flow was 2.42 million and capital expenditures -9.73 million, giving a free cash flow of -7.31 million.
| Operating Cash Flow | 2.42M |
| Capital Expenditures | -9.73M |
| Depreciation & Amortization | 5.26M |
| Net Borrowing | 3.98M |
| Free Cash Flow | -7.31M |
| FCF Per Share | -0.30 |
Margins
Gross margin is 15.80%, with operating and profit margins of 4.04% and 1.72%.
| Gross Margin | 15.80% |
| Operating Margin | 4.04% |
| Pretax Margin | 2.08% |
| Profit Margin | 1.72% |
| EBITDA Margin | 6.35% |
| EBIT Margin | 4.04% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 2.04%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 2.04% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 18.38% |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 2.04% |
| Earnings Yield | 11.07% |
| FCF Yield | -20.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 15, 2000. It was a forward split with a ratio of 2.
| Last Split Date | Mar 15, 2000 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Biokarpet has an Altman Z-Score of 1.43 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.43 |
| Piotroski F-Score | 7 |